Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Serum Institute

Serum Institute partners with Gates MRI to make experimental TB vaccine

Serum Institute will manufacture an experimental tuberculosis vaccine. This novel vaccine candidate is currently in late-stage clinical trials. Gates Medical Research Institute will transfer manufacturing technology and know-how. The company plans to invest over one hundred million dollars for production. This new shot could prevent millions of cases and save…

The Economic Times

India's Serum Develops New Vaccines For Malaria And Dengue

India's Serum Develops New Vaccines For Malaria And Dengue

Serum Institute, renowned for COVID-19 vaccines, now focusing on developing malaria and dengue vaccines to combat global health challenges.

Now a more efficacious, inexpensive malaria vaccine

Now a more efficacious, inexpensive malaria vaccine

Oxford University develops R21/MatrixM malaria vaccine; WHO recommends it; 3 countries approve; efficacy 75-79% in 5-17 mth olds; booster restores efficacy; cheaper than RTS,S/AS01.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Oxford-Serum institute malaria vaccine recommended for use by WHO

WHO recommends R21/Matrix-M malaria vaccine developed by Oxford and Serum Institute of India. Vaccine has met safety, quality and effectiveness standards. Serum Institute has established production capacity for 100 million doses/annum. Vaccine efficacy over 12 months is 75% at sites with high seasonal malaria transmission and 68% at sites with…

DGCI allows Serum Institute to export malaria vaccine to U.K.

The Drugs Controller General of India (DCGI) has granted permission to send two lakh doses of the vaccine

India develops indigenous cervical cancer vaccine to save millions of lives

India's homegrown cervical cancer shot, announced on Thursday, will be made available first to the country's poorest before being exported to other countries in need.

Radio France Internationale

Untapped global vaccine stash raises risks of new COVID variants

WASHINGTON — The world finds itself awash in COVID-19 vaccines, but governments can’t get them into arms fast enough, as hesitancy and logistical hurdles threaten to indefinitely extend the pandemic.

Tribune News Service

inkl

Read news from The Economist, FT, and more,
with one subscription

Nod for Covovax vaccine for 12-17 age-group

Nod for Covovax vaccine for 12-17 age-group

Serum Institute’s Adar Poonawalla says ‘younger age groups will follow shortly’

Low-cost HPV vaccine to be available soon

Low-cost HPV vaccine to be available soon

The Serum Institute of India will soon bring out a low-cost indigenous Human Papillomavirus (HPV) vaccine against cervical cancer, Dr. Umesh Shaligram, Executive Director of Serum Institute of India,

Covid-19: 3 shots okayed last year still not part of vaccination drive

Covid-19: 3 shots okayed last year still not part of vaccination drive

PUNE: Three vaccines against Covid-19 — Covovax, Corbevax and ZyCov-D — which received the Drug Controller General of India’s nod last year for emergency use in the country are yet to be used in the immunisation drive, raising questions on the delay in their utilisation. While Zydus Cadila’s ZyCoV-D was…

The Times of India

1

People

Adar Poonawalla

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Oxford University

The Gates Foundation

Serum Institute of India

the Serum Institute of India

Serum Institute

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Cervical Cancer

Places

400,295 stories

Washington D.C.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play